Advanced breast cancer: aetiology, pathogenesis and treatment
Intended for healthcare professionals
Clinical Previous    

Advanced breast cancer: aetiology, pathogenesis and treatment

Maggi Banning Senior lecturer, Advanced clinical practice, Brunel University, School of Health Sciences and Social Care, Middlesex

Even though the number of women affected by breast cancer continues to rise worldwide, aetiology remains unclear. As health educators nurses should encourage women, particularly those over 50, to undertake preventative measures such as breast self-examination and mammography, which are recognised means of identifying breast lumps. Breast tumours can be identified genetically and the HER2+ gene appears to cause the most prolific changes to breast tissue. When the use of trastuzumab is clearly indicated, its use in some cases has been rationed due to cost. Nurses have a key role to play in providing emotional support to women and advice on staying healthy.

Cancer Nursing Practice. 6, 3, 35-39. doi: 10.7748/cnp2007.04.6.3.35.c4206

Want to read more?

Already subscribed? Log in

OR

Unlock full access to RCNi Plus today

Save over 50% on your first 3 months

Your subscription package includes:
  • Unlimited online access to all 10 RCNi Journals and their archives
  • Customisable dashboard featuring 200+ topics
  • RCNi Learning featuring 180+ RCN accredited learning modules
  • RCNi Portfolio to build evidence for revalidation
  • Personalised newsletters tailored to your interests
Subscribe
RCN student member? Try Nursing Standard Student

Alternatively, you can purchase access to this article for the next seven days. Buy now

Or